Mature pericardial teratoma

Summary

Mature pericardial teratoma (MONDO:0004432) is a disease. A subtype of mature teratoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	mature pericardial teratoma
Mondo ID	MONDO:0004432
DOID	DOID:8012
NCIT	C6744
UMLS	C1334638
MedGen	233673
GARD	0024001
Anatomy (UBERON)	UBERON:0002407
Is cancer (heuristic)	no

Also known as: mature pericardial teratoma · mature teratoma of pericardium · mature teratoma of the pericardium · pericardium mature teratoma

Disease family

This is a subtype of mature teratoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › germ cell tumor › nongerminomatous germ cell tumor › teratoma › mature teratoma › mature pericardial teratoma

Related subtypes (3): central nervous system mature teratoma, mature ovarian teratoma, mature gastric teratoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.